About Affimed (AFMD)
Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company's product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research t... Read more
- USD0.51
- USD0.52
- USD0.47
- USD2.55
- -11.20%
- 33M
- 553.23k
- 543.46k
- 69M
- 0.45
- -76.50%
Stock News
yesterday
: Government shutdown: Video reportedly shows Rep. Jamaal Bowman pulling fire alarm as House scrambles to vote on spending bill
MarketWatch
yesterday
Commodities Corner: Why gasoline prices are set to fall even as oil marches toward $100 a barrel
MarketWatch
yesterday
Living With Climate Change: Here’s how El Niño will impact winter, including skiing and snowboarding plans
MarketWatch
yesterday
These are the top 4 Club stocks — and the bottom 4 — during the third quarter
CNBC
Unlock More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
